110.93
-2.28 (-2.01%)
| Penutupan Terdahulu | 113.21 |
| Buka | 114.07 |
| Jumlah Dagangan | 808,430 |
| Purata Dagangan (3B) | 896,919 |
| Modal Pasaran | 3,831,983,616 |
| Harga / Pendapatan (P/E TTM) | 22.78 |
| Harga / Pendapatan (P/E Ke hadapan) | 43.67 |
| Harga / Jualan (P/S) | 7.29 |
| Harga / Buku (P/B) | 7.95 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 May 2026 |
| Margin Keuntungan | 10.03% |
| Margin Operasi (TTM) | 19.12% |
| EPS Cair (TTM) | 1.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 48.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 110.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 194.67% |
| Nisbah Semasa (MRQ) | 9.10 |
| Aliran Tunai Operasi (OCF TTM) | 49.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -84.81 M |
| Pulangan Atas Aset (ROA TTM) | 4.21% |
| Pulangan Atas Ekuiti (ROE TTM) | 22.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | TransMedics Group, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.88 |
|
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.03% |
| % Dimiliki oleh Institusi | 121.56% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 175.00 (Oppenheimer, 57.76%) | Beli |
| Median | 165.00 (48.74%) | |
| Rendah | 130.00 (Stifel, 17.19%) | Pegang |
| Purata | 159.67 (43.94%) | |
| Jumlah | 4 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 132.34 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Stifel | 09 Mar 2026 | 130.00 (17.19%) | Pegang | 134.77 |
| Evercore ISI Group | 25 Feb 2026 | 170.00 (53.25%) | Beli | 131.85 |
| JP Morgan | 25 Feb 2026 | 149.00 (34.32%) | Pegang | 131.85 |
| Needham | 25 Feb 2026 | 174.00 (56.86%) | Beli | 131.85 |
| Oppenheimer | 25 Feb 2026 | 175.00 (57.76%) | Beli | 131.85 |
| Piper Sandler | 25 Feb 2026 | 160.00 (44.24%) | Beli | 131.85 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |